Evergreen Capital Management LLC Makes New Investment in Molina Healthcare, Inc $MOH

Evergreen Capital Management LLC purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,788 shares of the company’s stock, valued at approximately $831,000.

Several other large investors have also recently made changes to their positions in the business. Miller Global Investments LLC bought a new position in shares of Molina Healthcare in the fourth quarter worth approximately $27,000. Cromwell Holdings LLC grew its holdings in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the last quarter. Bogart Wealth LLC bought a new position in shares of Molina Healthcare in the third quarter worth approximately $39,000. MUFG Securities EMEA plc bought a new position in shares of Molina Healthcare in the second quarter worth approximately $48,000. Finally, SJS Investment Consulting Inc. grew its holdings in shares of Molina Healthcare by 6,225.0% in the third quarter. SJS Investment Consulting Inc. now owns 253 shares of the company’s stock worth $48,000 after purchasing an additional 249 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on MOH. Sanford C. Bernstein restated an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Zacks Research upgraded shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Truist Financial cut their target price on shares of Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a report on Tuesday, February 17th. TD Cowen cut their target price on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a report on Monday, February 9th. Finally, Wall Street Zen upgraded shares of Molina Healthcare from a “strong sell” rating to a “sell” rating in a report on Sunday, April 19th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $160.07.

Key Headlines Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Q1 EPS beat and FY26 guidance reaffirmed: Molina reported $2.35 EPS vs. $1.57 expected and kept FY26 guidance of at least $5.00 adjusted EPS and ~$42B in premium revenue — a clear near‑term positive for sentiment and valuation. Article Title
• Positive Sentiment: Cost control and MA‑Part D exit improve earnings quality: Management highlighted lower medical costs and is exiting unprofitable MAPD business (removing roughly $1B of revenue), which should boost margins and normalized earnings power per company commentary and analyst write‑ups. Article Title
• Neutral Sentiment: Earnings call details and analyst notes are mixed: Transcripts and recaps emphasize the tradeoff between profitability gains and top‑line shrinkage; some analysts are upgrading sentiment while others remain cautious. Article Title
• Neutral Sentiment: Coverage shows investor reactions and market commentary: Multiple outlets explain the big intraday move as a reaction to the beat + strategic exit, providing context but not new financials. Article Title
• Negative Sentiment: Revenue and membership declined: Q1 revenue came in roughly $10.8B (slightly below some estimates) and membership fell, reflecting the business shrinkage from the MAPD exit and lower premiums — headwinds for growth. Article Title
• Negative Sentiment: Profitability still depressed vs. year‑ago: Net income and EPS remain well below last year’s levels (profits down materially year‑over‑year), leaving investors wary that underlying normalized earnings improvement will take time. Article Title
• Negative Sentiment: Medicaid spending and market share uncertainty: Commentators note uncertainty around future Medicaid costs and whether Molina can regain membership/share, keeping analyst ratings mixed and limiting visibility on sustained margin improvements. Article Title
• Neutral Sentiment: Analysts are conflicted: Coverage highlights split views — some see a cleaner, higher‑quality earnings stream post‑MAPD exit, others worry the revenue shrink and Medicaid risks justify caution. Article Title

Molina Healthcare Stock Performance

NYSE:MOH opened at $175.89 on Friday. The stock has a market cap of $9.16 billion, a P/E ratio of 52.04 and a beta of 0.55. The firm’s fifty day simple moving average is $145.92 and its 200 day simple moving average is $159.28. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $333.00. The company has a quick ratio of 1.69, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, research analysts predict that Molina Healthcare, Inc will post 5.04 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.